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Abstract 20 
Millions of women use hormonal contraception and it has been suggested that such use may alter 21 
mate preferences. To examine the impact of oral contraceptive (pill) use on preferences, we 22 
tested for within-subject changes in preferences for masculine faces in women initiating pill use. 23 
Between two sessions, initiation of pill use significantly decreased women’s preferences for male 24 
facial masculinity but did not influence preferences for same-sex faces. To test whether altered 25 
preference during pill use influences actual partner choice, we examined facial characteristics in 26 
170 age-matched male partners of women who reported having either been using or not using the 27 
pill when the partnership was formed. Both facial measurements and perceptual judgements 28 
demonstrated that partners of women who used the pill during mate choice have less masculine 29 
faces than partners of women who did not use hormonal contraception at this time. Our data (A) 30 
provide the first experimental evidence that initiation of pill use in women causes changes in 31 
facial preferences and (B) documents downstream effects of these changes on real-life partner 32 
selection. Given that hormonal contraceptive use is widespread, effects of pill use on the 33 
processes of partner formation have important implications for relationship stability and may 34 
have other biologically relevant consequences. 35 
Key words: Oral contraception; pill; attractiveness; mate-choice; disruption; menstrual 36 
cycle 37 
Introduction 38 
Biological approaches to human attractiveness have documented several traits linked to mate 39 
preferences (Roberts and Little, 2008). These include preferences for visible facial and body 40 
traits, such as symmetry and sexually dimorphic cues (Thornhill and Gangestad, 1999; Little et 41 
al., 2011), vocal cues, such as pitch (Feinberg et al., 2006; Feinberg et al., 2008), and odour cues, 42 
such as those associated with genetic profiles (Wedekind, 1995; Roberts et al., 2008). Sexually 43 
dimorphic traits, relative masculinity/femininity, in faces have received much attention from 44 
those interested in evolutionary approaches to human preferences and perception (see e.g., 45 
Thornhill and Gangestad, 1999). This is because masculinity in male faces has been proposed to 46 
relate to both inter-sexual selection (Thornhill and Gangestad, 1999; Little et al., 2011), 47 
influencing attraction to the opposite-sex, and intra-sexual selection (Swaddle and Reierson, 48 
2003), relating to competition between members of the same sex. In terms of attractiveness to the 49 
opposite-sex, there are benefits that could be associated with sexual dimorphism: 1. indirect 50 
benefits, genetic benefits that are passed to offspring such as genes associated with strong 51 
immune systems, and 2. direct benefits, benefits that are directly passed to mates or offspring, 52 
such as resources or avoidance of disease. In line with links to both types of benefit, masculine-53 
faced men are perceived as dominant (Perrett et al., 1998),  report better health (Thornhill and 54 
Gangestad, 2006) and are physically stronger (Fink et al., 2007). However, masculine faced men 55 
also receive negative attributions, such as being seen as poor parents (Perrett et al., 1998), and 56 
have more short-term partners (Boothroyd et al., 2008) which suggests low investment in 57 
relationships. Facial masculinity in men then appears to be associated with a trade-off between 58 
investment and quality (Perrett et al., 1998). For example, masculinity may be negatively linked 59 
to levels of investment (direct benefit) but also positively to quality in terms of genes for 60 
health/dominance (indirect benefits) as well as current health/resources (direct benefits). Such a 61 
trade-off is consistent with variation in masculinity preferences, such as increased preferences 62 
for masculinity in short-term contexts (Little et al., 2002). 63 
Multiple studies have demonstrated that women’s preferences for various traits in various 64 
domains shift across the menstrual cycle (Rikowski and Grammer, 1999; Puts, 2005; Feinberg et 65 
al., 2006; Little et al., 2011). One of the most well-documented phenomena in studies examining 66 
cyclical preference shifts is a greater attraction to masculine faces at peak fertility in the 67 
menstrual cycle (Penton-Voak et al., 1999; Johnston et al., 2001; Little et al., 2007; Jones et al., 68 
2008; Little and Jones, 2012), a within-individual shift driven by variation in hormone levels 69 
across the cycle. This shift has been proposed to be adaptive in changing the preferences of 70 
women when they are most likely to become pregnant towards high quality males or in leading 71 
to attraction to more cooperative men when not likely to become pregnant (Penton-Voak et al., 72 
1999; Johnston et al., 2001; Little et al., 2007; Jones et al., 2008; Little and Jones, 2012).  73 
In view of hormonal differences between users and non-users of hormonal contraception, 74 
we might expect hormonal contraceptive use to influence these cyclical shifts in preferences. 75 
Indeed, studies of cycle effects have demonstrated a lack of (or weaker) shifts in preference 76 
among women using hormonal contraceptives (Penton-Voak et al., 1999; Alvergne and Lummaa, 77 
2010). Hormonal contraception also has the potential to change preferences across several 78 
different domains (Wedekind, 1995; Alvergne and Lummaa, 2010). For example, in the auditory 79 
domain preferences for masculinity in male vocal traits also appear to be weaker in pill users 80 
than non-users (Feinberg et al., 2008). Other research has examined preferences for the odour of 81 
genetically similar and dissimilar men. Some studies have found that preferences for men who 82 
are dissimilar at the major histocompatibility complex (MHC, a suite of genes coding for 83 
immune response), move towards preferences for genetically similar men in pill users 84 
(Wedekind, 1995; Roberts et al., 2008), indicating that pill use may change preferences in the 85 
smell domain.  86 
Given that the pill and other hormonal contraceptives are used by 12.5% of partnered 87 
women of reproductive age worldwide (United Nations, 2011), and that the proportion of US 88 
women, for example, who have ever used the contraceptive pill stands at 82% (Mosher and 89 
Jones, 2010), any alteration of preferences caused by hormonal contraceptive use is likely to be 90 
widespread. It is therefore important to examine how preferences and partner choice are affected 91 
by contraceptive pill use. Past research on the effects of the pill on preferences has generally 92 
examined only between-group comparisons, comparing different groups of pill users and non-93 
users. This means that there may exist other differences between users and non-users that 94 
account for variation in preference beyond hormonal changes associated with the pill (Roberts et 95 
al., 2008), such as differences in sexual behaviour (Little et al., 2002). Whether potential shifts in 96 
preference due to pill use lead to measurable differences in partner choices also remains to be 97 
addressed, and this is important because such differences could impact on the benefits and costs 98 
associated with preferring and partnering with masculine-faced men. We therefore examined the 99 
effect of pill use on preferences experimentally in Study 1 and measured the potential 100 
downstream influence of any altered preferences on partner choice in Study 2.  101 
Study 1: experimental test of preference change after initiation of pill use 102 
Previous studies of visual preferences for masculine traits documenting differences between 103 
women using and not using hormonal contraceptives have not been experimental in design, and 104 
have therefore been unable to demonstrate causative links between hormonal contraception and 105 
altered mate preferences. In our first study we experimentally examined change in preferences 106 
following initiation of pill use. We recruited an experimental group and a control group of 107 
women who completed two facial masculinity preference tests with an interval of approximately 108 
three months. Tests incorporated opposite- and same-sex faces manipulated using computer 109 
graphics techniques to appear more or less masculine (see Figure 1). Opposite-sex faces were 110 
judged for attractiveness as both a long-term and short-term partner, since relationship term is 111 
known to influence preferences (Penton-Voak et al., 1999; Little et al., 2002). The experimental 112 
group commenced pill use after the first test while the control group did not. If pill use affects 113 
preferences we expected that our experimental group would demonstrate a change in preference 114 
while our control group would not. We additionally predicted that if changes in preferences for 115 
sex-typicality reflect adaptation for mate choice then any change in preference for facial 116 
masculinity in the experimental group would be restricted to opposite-sex faces. 117 
Figure 1 about here 118 
Methods 119 
Participants 120 
Participants were 18 women in the experimental group who initiated use of the pill during the 121 
experiment (aged between 18 and 24, mean = 19.7, SD = 1.5) and 37 women in the control group 122 
(aged between 18 and 25, mean = 20.7, SD = 1.9).Three women (two in the experimental group 123 
and one in the control group) chose not to complete same-sex ratings. Participants were students 124 
or staff at Newcastle University, recruited by advertisement or word of mouth. They were 125 
offered £25 in compensation for time, travel and inconvenience. Participation requirements 126 
included not using any form of hormonal contraception either currently or within the preceding 127 
three months, not being pregnant, experiencing regular cycles, and being heterosexual. Women 128 
included in the pill group were either planning or considering to use the pill, and were willing to 129 
schedule initiation around the experiment. For ethical reasons, allocation to the pill/control group 130 
was entirely the decision of the volunteers, not the experimenters. The study was approved by 131 
the Ethics Committee of the Newcastle and North Tyneside NHS Trust.  132 
Stimuli 133 
To measure preferences for masculine features, we used five interactive face continuum trials of 134 
each sex which were constructed using composite faces made from 5 groups of male and female 135 
faces. The composite images were made by creating an average image from individual facial 136 
photographs (Benson and Perrett, 1993; Tiddeman et al., 2001). Each group of composite faces 137 
contributed to a single continuum trial and consisted of approximately 20 male and 20 female 138 
facial images of young adults in a neutral pose. 174 feature points were delineated on each face 139 
image. Using the linear difference between feature points in the average male and female shape, 140 
a continuum of 11 face shapes ranging from +50% masculinized to +50% feminized was 141 
constructed (Perrett et al., 1998). The images were made perfectly symmetrical by combining 142 
them with their mirror image prior to masculinity manipulation. For more details on the 143 
techniques see (Tiddeman et al., 2001). Figure 1 shows an example of the end-points for 144 
masculinized and feminized male and female faces. The final stimuli were 10 interactive tests 145 
which allowed for the on-screen transformation of a composite male or female face between a 146 
masculinized and feminized version of itself. These interactive tests were used in previous 147 
studies (Perrett et al., 1998; Penton-Voak et al., 1999). 148 
Procedure  149 
Following previous methods (Roberts et al., 2008), the preferences of all participants were tested 150 
twice, with a between-test interval of approximately 3 months to allow for hormonal changes to 151 
become stable and representative of continuous pill use (women were scheduled for their second 152 
test session during the third cycle, or pill packet, after the first test). To control for any influence 153 
of cycle, participants in the control group were tested in the follicular phase (between day 10-14 154 
of their cycle), when most likely to conceive, during both test sessions. In the experimental 155 
group, women were tested in the follicular phase (between day 10-14 of their cycle) in the first 156 
test session, began taking the pill at the beginning of their next menstrual cycle (approximately 2 157 
weeks later), and were tested for the second time on days 5-9 of their third pill packet 158 
(corresponding to days 10-14 following the first day of bleeding when not using the combined 159 
pill).  160 
Participants were informed at the outset that they would complete tests twice over 161 
approximately 3 months, but any change or consistency across tests due to this knowledge would 162 
apply to both the treatment and experimental groups and so could not be responsible for any 163 
between-group differences. In each test session, participants completed a short questionnaire 164 
assessing age, sex, and sexual orientation followed by the main test which consisted of selecting 165 
the most attractive image out of the continua. In each test session, we assessed participants’ 166 
preferences for masculinity in male and female faces using the 10 (5 male, 5 female) interactive 167 
continua. Participants judged the male sequences twice resulting in five trials in each of three 168 
blocks (short-term, long-term, and same-sex). Participants were cued to make their judgements 169 
of male faces based on either short- or long-term relationships by the message “alter the face 170 
until you think it is closest to the appearance you would find attractive for a short- [or long-] 171 
term relationship and then left click the mouse button”. Definitions of term were presented as in 172 
previous studies (Little et al., 2002):  173 
SHORT-TERM: You are looking for the type of person who would be attractive in a 174 
short-term relationship. This implies that the relationship may not last a long time. Examples of 175 
this type of relationship would include a single date accepted on the spur of the moment, an 176 
affair within a long-term relationship, and possibility of a one-night stand. 177 
LONG-TERM: You are looking for the type of person who would be attractive in a long-178 
term relationship. Examples of this type of relationship would include someone you may want to 179 
move in with, someone you may consider leaving a current partner to be with, and someone you 180 
may, at some point, wish to marry (or enter into a relationship on similar grounds as marriage). 181 
Female faces were judged using the question: “alter the face until you think it is most 182 
attractive and then left click the mouse button”. 183 
Participants judged male faces for both types of relationship context and female faces for 184 
attractiveness. The blocks and trials within each block were presented in a random order. During 185 
each trial, left or right (randomized between trials) mouse-movement altered the shape of the 186 
face in the on-screen image, making it more or less masculine. The starting point of the 187 
continuum was randomized in each trial. There was no time limit for decisions and a mouse click 188 
selected the most attractive image and also moved the participant on to the next trial. 189 
Calculating preferences for masculine faces 190 
For each trial a percentage preference was recorded. We calculated three scores for each test 191 
session: preference for masculinity in male faces for long-term relationships, preference for 192 
masculinity in male faces for short-term relationships, and preference for masculinity in female 193 
faces. To produce the scores, for each woman, we calculated the mean percentage of masculinity 194 
chosen in the five relevant trials (Perrett et al., 1998; Penton-Voak et al., 1999; Little et al., 195 
2002), with high scores indicating more masculine faces were preferred. The correlations 196 
between preferences in Session 1 and Session 2 for each of the three preference tests were all 197 
positive and significant (short-term: r = .415, p = .002, long-term: r = .289, p = .032, same-sex: r 198 
= .472, p = .001).  199 
We calculated the change in preference between the first and second test session for each 200 
of the three scores by subtracting scores in the first test session (Session 1) from scores in the 201 
second test session (Session 2). Positive scores indicated an increase in preferences for 202 
masculinity and negative scores indicated a decrease in preferences for masculinity across 203 
sessions. These difference scores are used as variables in the analysis below. 204 
Results 205 
A mixed-model 2x2 ANOVA was carried out with change in preference for masculinity in male 206 
faces as the dependent variable, term (long-term/short-term) as a within-participant factor and 207 
condition (experimental/control) as a between-participant factor. This analysis revealed a 208 
significant main effect of condition (F1,53 = 6.91, p = .011, ηp
2
 = .115). There was no significant 209 
main effect of term (F1,53 = 2.72, p = .105, ηp
2
 = .049) and no significant interaction between 210 
condition and term (F1,53 < 0.01, p = .976, ηp
2
 < .001). Means (collapsing across term) can be 211 
seen in Figure 1. The main effect of condition indicated that preferences for male facial 212 
masculinity were generally lower in the experimental, pill-using group at Session 2 compared 213 
with Session 1, a decrease not evident in the control group (Figure 1). Adding age as a covariate 214 
did not significantly affect the results of this analysis (see supplementary analysis). 215 
Given that there was no interaction between term and condition, we computed average 216 
change across short-term and long-term judgements. Restricting analysis to those women with 217 
both same-sex and opposite-sex scores (see experimental procedures), to compare opposite-sex 218 
to same-sex judgements, a mixed-model ANOVA was carried out with change in preference as 219 
the dependent variable, sex of face (male/female) as a within-participant factor and condition 220 
(experimental/control) as a between-participant factor. This analysis revealed a significant 221 
interaction between sex of face and condition (F1,50 = 4.48, p = .039, ηp
2
 = .082). There was also 222 
a significant main effect of sex of face (F1,50 = 8.69, p = .005, ηp
2
 = .148). There was no 223 
significant main effect of condition (F1,50 = 2.26, p = .142, ηp
2
 = .043). Independent samples t-224 
tests revealed that change in masculinity preferences was significantly different according to 225 
condition for judgements of opposite-sex faces (t50 = 2.81, p = .007, d = 0.795) but not same-sex 226 
faces (t50 = 0.31, p = .761, d = 0.088). Confirmatory one sample t-tests against no change (0), 227 
revealed that, for those in the experimental group, there was a significant decrease in preference 228 
for masculinity in male faces (t17 = 3.59, p = .002, d = 1.741) but not female faces (t15 = 1.05, p = 229 
.309, d = 0.542) and that for the control group there was no significant change for either male (t36 230 
= 0.33, p = .747, d = 0.110) or female faces (t35 = 0.95, p = .403, d = 0.321).  231 
Study 2: measurement of women’s partner’s facial masculinity according to pill use at the 232 
time of partner selection 233 
Changes in preference induced by pill use could lead to different partner choices in real life. 234 
Based on results of our experimental manipulation, we predicted that there would be differences 235 
in masculinity between the partners of those who met their partner while using or not using 236 
hormonal contraception. To test this, we conducted a second study on an age-matched sample of 237 
85 couples who reported using, and 85 couples who reported not using, the pill at the time of 238 
partnership formation. Standardized front-on neutral photographs were taken of the men. We 239 
determined men’s masculinity in three ways: 1. forced-choice judgements of the original images, 240 
2. forced-choice judgements of computer manipulated images capturing the shape differences 241 
between the partners of pill-users and non-users (see Figure 2), and 3. measurement of known 242 
sexually dimorphic face traits (see Figure 3). 243 
Figure 2 about here 244 
Figure 3 about here 245 
Methods 246 
Participants 247 
Target participants were 170 male-female couples (aged between 18 and 73, mean = 35.8, SD = 248 
11.3). All couples reported to be heterosexual. We collected data and images from 333 couples 249 
who were visitors to a science exhibition centre and who responded positively to a face-to-face 250 
invitation to participate. The only inclusion criteria were that both members of the couple were 251 
present. From this larger set, we created an age-matched final set: using reported male age, for 252 
each male who met their partner while using the pill we searched for a same aged male who met 253 
their partner while not using the pill (nor any other form of hormonal contraception). Men for 254 
which there were no remaining age matches were excluded. Where multiple matches were 255 
available, men were selected randomly.  256 
An additional 30 participants (20 women, 10 men, aged between 17 and 41, mean = 26.0, 257 
SD = 5.5) judged pairs of the original face images for relative masculinity. A different set of 80 258 
participants (56 women, 24 men, aged between 17 and 57, mean = 26.1, SD = 8.5) judged pairs 259 
of the manipulated face images for relative masculinity. Both sets of raters were recruited online 260 
and completed the test over the Internet. 261 
 The study was approved by the Ethics Committee of the Department of Psychology, 262 
University of Stirling. 263 
Photography 264 
Photographs of the men were taken under standardized lighting conditions and participants posed 265 
with a neutral expression. To equate size, all images were aligned to standardize the position of 266 
the pupils in the image.  267 
Stimuli for ratings 268 
For judgements of the original images, the images were resized to 280 x 325 pixels. To create 269 
computer manipulated images capturing the shape differences between the partners of pill-users 270 
and non-users, we first created one composite face for each group of men, using the method 271 
described for Study 1. To make the transformed faces, we manipulated 10 male base faces +50% 272 
towards the pill user’s partner or +50% towards the non-user’s partner using the shape difference 273 
between the two composites, creating 10 pairs of images that capture the differences between the 274 
composites (partners of pill users and non-users). These transformed faces were made using the 275 
same way methods used to manipulate masculinity in Study 1. 276 
Procedure for ratings 277 
In both rating studies, participants were presented on a computer with a brief questionnaire 278 
followed by pairs of images and were asked to “Choose the most masculine image out of the 279 
pair”. Selecting an image moved on to the next trial. The order of the trials and the side of 280 
presentation was randomized. There was no time limit for judgements. For the original images 281 
test there were 85 trials and for the manipulated images test there were 10 trials. 282 
Measurements 283 
Sexual dimorphism measures were taken from points marked on facial features used in previous 284 
studies (Penton-Voak et al., 2001; Little et al., 2008b) and can be seen in Figure 3. Three 285 
measurements were taken: Cheekbone Prominence, Jaw Height/Lower Face Height, and Face 286 
Width/Lower Face Height. These measurements have been found to be sexually dimorphic in 287 
previous studies (Penton-Voak et al., 2001; Little et al., 2008b). To compute an overall measure 288 
of masculinity, these variables were normalised and summed: JH/LFH - ((CP + FW/LFH)/2). 289 
High scores on this measure indicated masculine face shape. Two markers independently placed 290 
points, and the average score for each face was then calculated (correlation between score for the 291 
two markers was: r = .935). 292 
Results 293 
A one sample t-test comparing choice between pairs of original faces of the two groups of men 294 
(partners of pill users and non-users at relationship formation) revealed that the partners of non-295 
users were seen as significantly more masculine, both using average scores for each rater (t29 = 296 
7.13, p < .001, d = 2.648) and average scores for each face (t84 = 2.14, p = .035, d = 0.467). A 297 
one sample t-test for the manipulated face images, in which shape cues were isolated, using 298 
average scores for each rater again revealed that the partners of non-users were seen as 299 
significantly more masculine (t79 = 3.38, p = .001, d = 0.761). Finally, a paired sample t-test on 300 
the metric masculinity for each face also revealed that men whose relationships began while their 301 
partner used the pill had significantly less morphologically masculine faces than those whose 302 
partners did not use the pill at relationship formation (t84 = 2.00, p = .048, d = 0.436). 303 
Discussion 304 
Our first study represents the first experimental demonstration that pill initiation changes visual 305 
preferences for a trait associated with mate-quality, complementing within-subject 306 
demonstrations that pill use can change odour preferences for genetic similarity (Roberts et al., 307 
2008). Effects were only seen for preferences for opposite-sex faces, suggestive that the effects 308 
of pill use influence mate preferences but not general preferences for faces. Experimental studies 309 
are critical because behavioural variables, such as sexual behaviour (Little et al., 2002), that 310 
could impact on preference and mate choice differ between pill-users and non-users (Roberts et 311 
al., 2008). The second study builds on our experimental demonstration of changed preferences, 312 
documenting a downstream consequence of pill use during formation of actual partnerships, 313 
suggesting that altered preferences lead to altered mate choice. Original face images and 314 
computer generated images of women’s partners, whom they met while using the pill, were 315 
judged as less masculine than those of women who met their partner when not using the pill. 316 
Facial measurements of the masculinity of the women’s partners were in line with this effect. 317 
The effect size for the measurements by face was smaller than the effect size for the perceptual 318 
ratings by rater, potentially reflecting that the facial measurements used do not capture all of the 319 
variation in masculinity between the faces (e.g., color cues are absent), although we note that this 320 
appears also due to variation in the type of analysis, as more similar effect sizes are seen when 321 
comparing the effect size for the measurements by face and the perceptual ratings by face. 322 
We focused on facial masculinity because researchers have proposed that sexually 323 
dimorphic facial traits (masculine appearance in men and feminine appearance in women) may 324 
be cues to indirect (genetic benefits to offspring) and direct fitness benefits (Thornhill and 325 
Gangestad, 1999). Masculinity, though, is not universally preferred by women and many 326 
previous studies demonstrate individual differences in preference for masculine and feminine 327 
traits in faces ( Little et al., 2011). While masculine-faced men are healthier (Rhodes et al., 2003; 328 
Thornhill and Gangestad, 2006), physically stronger (Fink et al., 2007), and more facially 329 
symmetric (Little et al., 2008a) than their feminine faced counterparts, choosing a masculine 330 
partner also carries a cost. Masculine-faced men are seen to possess less pleasant personality 331 
traits (Perrett et al., 1998) and are more likely to pursue short-term relationships than feminine-332 
faced men (Boothroyd et al., 2008). As might be expected, masculine faces are seen as more 333 
dominant but not as possessing traits that would be desirable in a long-term partner (Perrett et al., 334 
1998). Initiation of pill use impacts preferences for these traits, suggesting that associated 335 
hormonal changes alter the balance in favour of cooperative feminine partners over 336 
dominant/healthy masculine partners. Hormonal contraceptives work by altering hormonal 337 
fluctuations that occur during the natural menstrual cycle, through negative feedback effects on 338 
the hypothalamus and anterior pituitary gland, which suppress gonadotropin release and inhibit 339 
follicular development and ovulation (Rivera et al., 1999). They consist of synthetic formulations 340 
of either a progestogen (e.g., the “minipill”, or progestin-only pill) or a dose of both an estrogen 341 
and a progestogen (e.g., the “combined pill”). The oral contraceptive pill, and other hormone-342 
based contraceptives (e.g., patch or implant) work by suppressing ovarian hormones, which 343 
alters the hormonal profile of the woman, and results in a levelling effect in concentrations of 344 
estrogen and progesterone (Rivera et al., 1999; Benagiano et al., 2006).This in turn works to 345 
prevent follicular development and subsequent hormonal shifts associated with ovulation (Frye, 346 
2006). Women’s levels of circulating testosterone are also suppressed during hormonal 347 
contraceptive use (e.g., Alexander et al., 1990), which may contribute to change in women’s 348 
sexuality, at least in some individuals (e.g., Graham et al., 2007). These changes in hormonal 349 
profile likely underpin the changes in preference and choice seen in our studies. For example, 350 
because the hormonal profile of pill users reflects low likelihood of conception and is thus in this 351 
specific respect closer to that seen during pregnancy, a time when cooperation and investment is 352 
valued more than other measures of quality, women using hormonal contraceptives may prefer 353 
partners displaying visual cues to cooperation and not genetic quality (Alvergne and Lummaa, 354 
2010).  Alternatively, pill users may not necessarily be more or less attracted to different faces, 355 
but rather they may be less attentive to facial masculinity because they do not experience a 356 
periovulatory increase in visual attention towards mate-salient cues that is normally experienced 357 
by non-users (Anderson et al., 2010). Through any of these hormonally mediated mechanisms, 358 
changes in partner choice that are associated with pill use could then affect subsequent 359 
relationship quality and stability (Roberts et al., 2012) as well as potentially influencing the 360 
health of future offspring (Havlicek and Roberts, 2009; Alvergne and Lummaa, 2010). 361 
Although we think our results bring important evidence for an influence of pill use in 362 
shaping women’s partner choice, they raise some additional questions which warrant further 363 
examination. First, our design in Study 1 tested women’s preference change following initiation 364 
of pill use, but not following discontinuation. A further study might therefore compare 365 
preferences of pill users before and after discontinuation, with the prediction that their 366 
masculinity preference would increase as they resume cycling. Second, future studies could 367 
explore dose-dependent effects of oral contraceptives on preference. Women using pill brands 368 
with higher doses of synthetic estrogen experience higher levels of sexual jealousy (Cobey et al., 369 
2011) and related behaviour (Welling et al., 2012) than those using lower-dose brands, and it is 370 
possible that dosage also influences other psychological variables including partner preferences. 371 
Unfortunately, we were unable to investigate this in our study as many of the women in Study 2 372 
could not recall which pill brand they had been using when they met their partner. Third, future 373 
work could investigate an alternative interpretation of the results of Study 2, which is that men 374 
are more active in choosing long-term partners than women and that masculine-faced men prefer 375 
non-users over users. This could be a plausible explanation because more masculine men might 376 
compete more effectively for attractive women, and women appear most attractive at peak 377 
fertility (e.g., Roberts et al., 2004; Havlicek et al., 2006). However, at this point, we think that 378 
this is a less likely explanation for the observed effect because, as in non-human animals, 379 
selection on female choice is thought to be stronger than on male choice. It also appears more 380 
parsimonious that effects of pill use are directly exerted on the female user than indirectly on 381 
potential male partners, and, furthermore, Study 1 shows a consistent effect on women’s 382 
preference for the relevant facial trait. Finally, the results of Study 2 could be explained by pill 383 
users having stronger preference for another male trait which is itself correlated with lower facial 384 
masculinity. This could be an interesting possibility but, again, the results presented in Study 1 385 
provide support for a preference change based directly on sexually dimorphic facial cues. 386 
We also note that in Study 1 we tested women in the follicular phase, when preference 387 
for masculinity is usually elevated (Penton-Voak et al., 1999), and that, in real life, long-term 388 
partner selection is likely an extended process, occurring across multiple cycles in which women 389 
can vary in their attraction to masculinity and femininity. It is therefore possible that pill use may 390 
have a smaller effect on women’s preferences than indicated by our effect size, if preferences 391 
were to be averaged across measures at multiple points across the cycle. Even if this is the case, 392 
however, the results of Study 2 indicate that effects of pill use on preference remain sufficiently 393 
substantial to exert an effect on actual partner selection.  394 
Despite their influence on partner preferences, it is important to also note that modern 395 
contraceptive methods have improved quality of life around the world by reducing the frequency 396 
of unintended pregnancies and maternal deaths (Alvergne and Lummaa, 2010). They have also 397 
given women much more control over their reproductive lives, enabling them to postpone 398 
childbearing, increase their educational level, and pursue more varied career paths (Shah et al., 399 
2001; Goldin and Katz, 2002). The pill is also associated with several demonstrated health 400 
benefits through stabilization of hormonal fluctuations, such as helping to control premenstrual 401 
syndrome and reduce acne (Sherif, 1999). Nevertheless, the impact of the pill on partner choice 402 
and the implications of this impact may have been generally underappreciated. Given that the pill 403 
and other hormonal contraceptives are used by millions of women of reproductive age 404 
worldwide, our data could allow women to weigh the costs and benefits of pill use versus other 405 
contraceptive methods.  406 
 407 
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Figure Legends 514 
Figure 1: Example stimuli and results for Experiment 1. Left: Feminized (left) and 515 
masculinized (right) male and female faces. Participants saw an interactive continuum. 516 
Right: Change in women’s percentage preference for facial masculinity (+/- 1 SEM) in 517 
opposite-sex (experimental group N =18, control group N = 37) and same-sex (experimental 518 
group N = 16, control group N = 36) faces according to condition (experimental versus 519 
control). 520 
 521 
Figure 2: Composite images of male partners according to pill use and results for Study 2. 522 
Left: Transformed faces based on pill use. Partner of pill user (+50% top left), partner of 523 
non-user (+50%, right). For illustration here, we extrapolated the differences: partner of 524 
pill user (+200% bottom left), partner of non-user (+200%, bottom right). Right: Top: 525 
Percent choice of non-users partner’s face as more masculine (+/- 1 SEM) for original 526 
(rater N = 30) and transformed rater (N = 80) faces in Study 2. Bottom: Z-score measured 527 
masculinity for the partners (N = 85 in each group) of pill users and non-users (+/- 1 SEM). 528 
 529 
Figure 3: Sexual dimorphism was calculated by measuring distance between facial features 530 
and calculating three ratios: Cheekbone Prominence (D3/D6), Jaw Height/Lower Face 531 
Height (D9/D8), and Face Width/Lower Face Height (D3/D8). Where two features were 532 
available for a height distance measure (e.g., D8 uses the average of both eye points), the 533 
average height was used. The numbers assigned are to keep features labelled consistently 534 
with previous studies (Penton-Voak et al., 2001; Little et al., 2008b). 535 
536 
Figure 1. 537 
 538 
539 
Figure 2. 540 
 541 
542 
Figure 3. 543 
 544 
545 
Supplementary Material 546 
Supplementary analysis for Study 1: 547 
Baseline preferences for masculinity 548 
One-sample t-tests against chance (0% masculinity preference) revealed that, in the first test 549 
session, women demonstrated a significant preference for male facial masculinity for short-term 550 
relationships (t54 = 3.43, p = .001, d =0.933) and significant preferences for femininity in female 551 
faces (t52 = 10.77, p < .001, d = 2.99). In the first test session, women judging male faces for 552 
long-term relationships expressed no significant masculinity preference (t54 = 1.33, p = .189, d = 553 
0.362). A paired sample t-test revealed a non-significant difference between long- and short-term 554 
male facial masculinity preferences (t54 = 1.65, p = .104, d = 0.449). Women preferred more 555 
masculine faces for short-term than long-term relationship judgments and this difference would 556 
approach significance in a 1-tailed test (one-tailed p = .052). Independent samples t-tests 557 
revealed no significant differences in masculinity preferences at the first test session for short-558 
term (t53 = 0.29, p = .777, d = 0.080), long-term (t53 = 0.03, p = .975, d = 0.008), or same-sex (t51 559 
= 0.96, p = .340, d = 0.269) judgments.  560 
 561 
Controlling for participant age 562 
Participants were older in the experimental condition than in the control condition, although this 563 
was on the border of significance using an independent samples t-test (t53 = 2.00, p = .051, d = 564 
0.549). In order to rule out the possibility that age was confounding the effects of pill use on 565 
preferences, we reran both of the relevant ANOVAs with age as a covariate. Controlling for age 566 
did not change the pattern of results. Additionally, age was not significantly correlated with 567 
either change in average preference for masculinity in opposite-sex (r = -.055, p = .692) or same-568 
sex faces (r = -.146, p = .303).  569 
 570 
Preference change using mean scores separately for Session 1 and Session 2 571 
We present an analysis using difference scores between Session 1 and Session 2 in the main 572 
article text. Here we present an alternative analysis using the mean rating scores separately from 573 
Session 1 and Session 2. 574 
To address changes in preferences for men’s faces, a mixed-model ANOVA was carried 575 
out with preference for masculinity as the dependent variable, session (Session 1/Session 2) and 576 
term (short-term/long-term) as within-participant factors and condition (experimental/control) as 577 
a between-participant factor. This analysis revealed a significant interaction between session and 578 
condition (F1,53 = 7.05, p = .010, ηp
2
 = .117). There was also a significant main effect of session 579 
(F1,53 = 8.79, p = .005, ηp
2
 = .142) and a close to significant main effect of condition (F1,53 = 3.28, 580 
p = .142, ηp
2
 = .058), although both were qualified by the above interaction. No other effects or 581 
interactions were significant (all F1,53 < 2.66, all p > .109, all ηp
2
 < .048). Mean preferences can 582 
be seen in Figure S1. Splitting by condition, follow-up paired sample t-tests confirmed that 583 
preferences for masculinity were significantly lower in Session 2 than Session 1 for those in the 584 
experimental group (short-term, t17 = 2.91, p = .010, d = 1.411, long-term, t17 = 2.45, p = .025, d 585 
= 1.188) but not those in the control group (short-term, t36 = 1.28, p = .209, d = 0.427, long-term, 586 
t36 = 0.71, p = .481, d = 0.237). 587 
 For women’s faces, a mixed-model ANOVA was carried out with preference for 588 
masculinity as the dependent variable, session (Session 1/Session 2) as a within-participant 589 
factor and condition (experimental/control) as a between-participant factor. This analysis 590 
revealed no significant interaction between session and condition (F1,50 = 0.09, p = .761, ηp
2
 = 591 
.002). There was no significant main effect of session (F1,50 = 1.64, p = .206, ηp
2
 = .032) and no 592 
significant main effect of condition (F1,50 = 0.66, p = .421, ηp
2
 = .013). Mean preferences can be 593 
seen in Figure S1. Splitting by condition, follow-up paired sample t-tests confirmed that 594 
preferences for masculinity were not significantly different in Session 2 than Session 1 for those 595 
in the experimental group (t15 = 1.05, p = .309, d = 0.542) or those in the control group (t35 = 596 
0.85, p = .403, d = 0.287). 597 
598 
 599 
Figure S1: Women’s percentage preference for facial masculinity for Session 1 and Session 600 
2 (+/- 1 SEM) in opposite-sex (top, experimental group N = 18, control group N = 37) and 601 
same-sex (bottom, experimental group N = 16, control group N = 36) faces according to 602 
condition (experimental versus control). 603 
 604 
 605 
Supplementary analysis for Study 2: 606 
Influence of couple age 607 
In order to address if couple age was related to the relationship between pill use and partner 608 
choice in the matched faces of Study 2 we used two scores: the mean choice of non-pill using 609 
women’s male partners as more masculine and the difference in measured masculinity between 610 
the partners of pill users and non-users- at the time of relationship formation (calculated as non-611 
users partner minus pill users partner so that positive scores indicate that that the partners of non-612 
users were more masculine).  These scores represented an effect of pill use on masculine partner 613 
choice, with higher scores indicating greater effects of the pill on the selection of masculine 614 
partners.  615 
We correlated the two measures, the perceptual score and metric score, with male age. 616 
For the perceptual measure, this revealed a non-significant relationship between age and the 617 
relationship between pill use and partner choice (r = -.078, p = .476). For the metric score, this 618 
revealed a close to significant relationship between age and the relationship between pill use and 619 
partner choice (r = .191, p = .080). The latter effect is suggestive that the effect of pill use on 620 
partner choice may be most apparent in older couples, although the fact that it is not significant 621 
and the absence of this effect (which even suggests the opposite direction of relationship) for the 622 
perceptual measures means it should be treated with caution. 623 
 624 
